LONGITUDINAL PLASMA CELL FREE DNA BRAFV600E LEVELS AS A BIOMARKER OF DISEASE STATUS IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS (LCH)

被引：0
|
作者：
Morales, Sonia [1 ]
Brown, Carol [1 ]
Johnson, Natalie [1 ]
Kasper, Kirsten [1 ]
Zabokrtsky, Keri [1 ]
Torno, Lilibeth [1 ]
机构：
[1] Childrens Hosp Orange Cty CHOC, Orange, CA USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S34 / S34
页数：1
相关论文
共 50 条
  • [21] Clinicopathological features and BRAFV600E mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis
    Huo, Zhen
    Lu, Tao
    Liang, Zhiyong
    Ping, Fan
    Shen, Jie
    Lu, Jingjing
    Ma, Wenbing
    Zhao, Dachun
    Zhong, Dingrong
    DIAGNOSTIC PATHOLOGY, 2016, 11
  • [22] Clinicopathological features and BRAFV600E mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis
    Zhen Huo
    Tao Lu
    Zhiyong Liang
    Fan Ping
    Jie Shen
    Jingjing Lu
    Wenbing Ma
    Dachun Zhao
    Dingrong Zhong
    Diagnostic Pathology, 11
  • [23] BRAFV600E vs cell of origin: what governs LCH?
    McClain, Kenneth L.
    Chakraborty, Rikhia
    BLOOD, 2021, 138 (14) : 1203 - 1204
  • [24] A phase 2 study of HLX208, a BRAFV600E inhibitor, in adult patients with Langerhans cell histiocytosis and/or Erdheim-Chester disease harboring BRAFV600E mutation.
    Cao, Xin-Xin
    Wu, Yu
    Liu, Peng
    Ding, Tianling
    Ye, Hongying
    Cai, Zhen
    Zhang, Yu
    Hu, Chen
    Hou, Xiaoli
    Yang, Guiyu
    Wang, Qingyu
    Zhu, Jun
    Li, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] BRAFV600E Mutation in Cell-Free DNA, Rather than in Lesion Tissues, at Diagnosis Is An Independent Prognostic Factor in Children with Langerhans Cell Histiocytosis
    Wang, Chan-Juan
    Cui, Lei
    Ma, Hong-Hao
    Wang, Dong
    Zhang, Li
    Lian, Hong-Yun
    Li, Wei-Jing
    Zhang, Qing
    Wang, Tian-You
    Li, Zhi-Gang
    Zhang, Rui
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (07) : 1316 - 1323
  • [26] BRAFV600E PROMOTES MYELOID SKEWING IN MULTISYSTEMIC LANGERHANS CELL HISTIOCYTOSIS HUMANIZED MOUSE MODEL
    Biavasco, R.
    Norelli, M.
    Camisa, B.
    Cesana, D.
    Gallina, P.
    Gentner, B.
    Ponzoni, M.
    Dagna, L.
    Bondanza, A.
    Montini, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 126 - 126
  • [27] VE1 immunohistochemistry to determine BRAFV600E mutation in Langerhans-cell histiocytosis
    Casado-Lopez, Esther
    Rey-Garcia, Jimena
    Galan-Gomez, Victor
    Pozo-Kreillinger, Jose Juan
    Perez-Martinez, Antonio
    ANALES DE PEDIATRIA, 2022, 97 (05): : 352 - +
  • [28] MAPPING THE BRAFV600E HEMATOPOIETIC CLONE OF ADULT MULTI-SYSTEM LANGERHANS CELL HISTIOCYTOSIS
    Milne, Paul
    Collin, Matthew
    Bigley, Venetia
    Bacon, Chris M.
    McGovern, Naomi
    Windebank, Kevin
    Allen, Carl
    McClain, Kenneth
    Haniffa, Muzlifah
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S12 - S12
  • [29] High prevalence of BRAFV600E in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis
    Carrere, Xiomara
    Pinto, Nicolas
    Gene Olaciregui, Nagore
    Galluzzo, Laura
    Rossetti, Estefania
    Celis Passini, Veronica
    Salvador Marcos, Noelia
    Chantada, Guillermo
    Braier, Jorge
    Lavarino, Cinzia
    Felizzia, Guido
    PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
  • [30] HIGH PREVALENCE OF BRAFV600E IN PATIENTS WITH CHOLESTASIS, SCLEROSING CHOLANGITIS OR LIVER FIBROSIS SECONDARY TO LANGERHANS CELL HISTIOCYTOSIS
    Pinto, Nicolas
    Carrere, Xiomara
    Rosetti, Estefania
    Passini, Veronica Celis
    Galluzzo, Laura
    Olaciregui, Nagore Gene
    Marcos, Noelia Salvador
    Chantada, Guillermo
    Braier, Jorge
    Lavarino, Cinzia
    Felizzia, Guido
    PEDIATRIC BLOOD & CANCER, 2021, 68
12345